GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Degree of Financial Leverage

YIFAN PHARMACEUTICAL CO (SZSE:002019) Degree of Financial Leverage : 0.86 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage for the quarter that ended in Mar. 2024 was 0.86. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage or its related term are showing as below:

SZSE:002019's Degree of Financial Leverage is ranked better than
57.68% of 1042 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs SZSE:002019: 0.86

YIFAN PHARMACEUTICAL CO Degree of Financial Leverage Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Degree of Financial Leverage Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 5.84 0.94 2.32 0.94

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.71 1.34 0.94 0.86

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage falls into.



YIFAN PHARMACEUTICAL CO Degree of Financial Leverage Calculation

YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage for the quarter that ended in Mar. 2024 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( -0.383 (Mar. 2024) / 0.103 (Mar. 2023) - 1 )/( -683.694 (Mar. 2024) / 151.708 (Mar. 2023) - 1 )
=-4.7184/-5.5066
=0.86***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


YIFAN PHARMACEUTICAL CO Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines